# BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
> **ANDA202940** · Abbreviated New Drug Application (Generic) · Sponsor: PHARM ASSOC · Approved 2014-07-21
## Drug
- **FDA Application Number:** ANDA202940
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
- **Generic name:** BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE
- **Active ingredients:** BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PHARM ASSOC
- **Manufacturer:** PAI Holdings, LLC dba PAI Pharma
- **First approval:** 2014-07-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202940)
---
*MORVS · CC0 1.0*